Delivery Order SPE2DR25D1202-SPE2DR26F73KM
- Not listed
- The Defense Logistics Agency awarded a $11,572.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen injectors, with an ultimate completion date of December 16, 2025. This non-set-aside award represents a single delivery order transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,353.44 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13,898.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors, with an ultimate completion date of December 19, 2025. This non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,081.35 for Mounjaro 10 mg/0.5 ml pen injectors on July 23, 2025, with ultimate completion by July 24, 2025. This firm fixed-price, competitively awarded contract involves pharmaceutical delivery to support federal medical procurement needs. The contract is issued without set-aside designation, reflecting open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,843.94 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by November 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply contract. The award represents a continuation...
- The Defense Logistics Agency awarded a delivery order valued at $1,159.40 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen injections with an ultimate completion date of December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a distribution hub for federal pharmaceutical...
- The Defense Logistics Agency awarded a $10,205.97 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on December 5, 2025, with completion expected by December 8, 2025. This competitively awarded, firm fixed-price delivery order represents pharmaceutical supply for federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.10 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors on November 6, 2025, with completion targeted for November 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $4,979.42 on December 10, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injections. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by December 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.03 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73KMDelivery Order
The Defense Logistics Agency awarded a $24,139.06 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime IDC, designated SPE2DX, functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The DLA Troop Support is developing Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple regional awards, positioning AmerisourceBergen among the key vendors serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 12/21/25 |